William Roy Smythe

Chief Executive Officer at Xilis.

Raised on Xilis filings

$19.4M

of $19.4M offered across 1 Form D filing

Company

Biotech · Durham, NC

Miniature tumor models that match patients to cancer drugs

Miniature tumor models that match patients to cancer drugs

Xilis Form D filings
Filed	Security	Sold of offered	Filing
Apr 25, 2025	Equity	$19.4M/ $19.4M	Form D

Also named on Xilis filings